Annual total expenses:
$89.02M+$17.44M(+24.36%)Summary
- As of today (August 22, 2025), ELVN annual total expenses is $89.02 million, with the most recent change of +$17.44 million (+24.36%) on December 31, 2024.
- During the last 3 years, ELVN annual total expenses has risen by +$64.28 million (+259.84%).
- ELVN annual total expenses is now at all-time high.
Performance
ELVN Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$25.34M-$3.21M(-11.24%)Summary
- As of today (August 22, 2025), ELVN quarterly total expenses is $25.34 million, with the most recent change of -$3.21 million (-11.24%) on June 30, 2025.
- Over the past year, ELVN quarterly total expenses has increased by +$5.38 million (+26.99%).
- ELVN quarterly total expenses is now -11.24% below its all-time high of $28.54 million, reached on March 31, 2025.
Performance
ELVN Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ELVN Total expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +24.4% | +27.0% |
3 y3 years | +259.8% | +185.0% |
5 y5 years | +279.4% | +148.3% |
ELVN Total expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +6082.8% | -11.2% | +178.7% |
5 y | 5-year | at high | +6082.8% | -11.2% | +178.7% |
alltime | all time | at high | +6082.8% | -11.2% | +178.7% |
ELVN Total expenses History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $25.34M(-11.2%) |
Mar 2025 | - | $28.54M(+23.1%) |
Dec 2024 | $89.02M(+24.4%) | $23.18M(+0.1%) |
Sep 2024 | - | $23.16M(+16.1%) |
Jun 2024 | - | $19.95M(-12.3%) |
Mar 2024 | - | $22.74M(+17.4%) |
Dec 2023 | $71.58M(-4910.8%) | $19.37M(-6.7%) |
Sep 2023 | - | $20.77M(+24.2%) |
Jun 2023 | - | $16.72M(+13.6%) |
Mar 2023 | - | $14.72M(-145.7%) |
Dec 2022 | -$1.49M | -$32.19M(-405.0%) |
Sep 2022 | - | $10.55M(+18.7%) |
Jun 2022 | - | $8.89M(+2.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $8.67M(-39.5%) |
Dec 2021 | $24.74M(-40.2%) | - |
Dec 2021 | - | $14.32M(+4.9%) |
Sep 2021 | - | $13.65M(+3.7%) |
Jun 2021 | - | $13.16M(+28.3%) |
Mar 2021 | - | $10.26M(-10.9%) |
Dec 2020 | $41.36M(+76.3%) | $11.52M(-7.3%) |
Sep 2020 | - | $12.42M(+21.7%) |
Jun 2020 | - | $10.20M(+41.4%) |
Mar 2020 | - | $7.21M(+9.0%) |
Dec 2019 | $23.46M(+107.0%) | - |
Sep 2019 | - | $6.62M |
Dec 2018 | $11.34M(>+9900.0%) | - |
Dec 2017 | $0.00 | - |
FAQ
- What is Enliven Therapeutics, Inc. annual total expenses?
- What is the all time high annual total expenses for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual total expenses year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly total expenses?
- What is the all time high quarterly total expenses for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly total expenses year-on-year change?
What is Enliven Therapeutics, Inc. annual total expenses?
The current annual total expenses of ELVN is $89.02M
What is the all time high annual total expenses for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual total expenses is $89.02M
What is Enliven Therapeutics, Inc. annual total expenses year-on-year change?
Over the past year, ELVN annual total expenses has changed by +$17.44M (+24.36%)
What is Enliven Therapeutics, Inc. quarterly total expenses?
The current quarterly total expenses of ELVN is $25.34M
What is the all time high quarterly total expenses for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly total expenses is $28.54M
What is Enliven Therapeutics, Inc. quarterly total expenses year-on-year change?
Over the past year, ELVN quarterly total expenses has changed by +$5.38M (+26.99%)